Pharma Foods International Co., Ltd.(2929.T), a Japanese functional food ingredients developer, on Thursday reported a sharp decline in profit for fiscal year 2025 despite improved sales, hurt mainly by expenses.
Looking forward, the company issued fiscal year 2026 guidance, expecting higher profit and sales, but lower operating profit.
In the Tokyo market, the shares were trading 15.33% lower at 878 yen.
For fiscal 2026, Pharma Foods expects profit attributable to owners of parent to grow 171.7% year-over-year to 1 billion yen or 34.64 yen per share.
Meanwhile, operating profit is expected to decline 36.6% from the year to 1.5 billion yen for 2026.
The company expects net sales to improve 4.2% year on year, amounting to 68 billion yen.
For the full year 2025, profit attributable to owners of parent declined 88.5% to 368 million Japanese yen from 3.21 billion Japanese yen a year ago.
Basic earnings per share shrank to 12.83 yen from 112.71 yen last year.
Operating profit slipped 53.7 percent to 2.37 billion yen from 5.11 billion yen a year ago.
However, net sales of the firm improved 5% to 65.26 billion yen from 62.15 billion yen in the prior year.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.